Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical bFGF gelatin hydrogel for olfactory dysfunction pilot study
jRCTs061240046Recruiting
- Start
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of trafermin in Olfactory disorder. Primary endpoint: Improvement in average cognitive threshold at 3 months. Started Jan 2025; status: recruiting.
02
Drugs
trafermin
03
Conditions
Olfactory disorder
Beyond the preview
Go deeper on jRCTs061240046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061240046.